Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding Revolutionaries in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Senior Director, Lung Regional Insights & Engagement, reporting into VP or NSCLC Marketing with dotted line to Executive Director, US KOL Regional Insights & Engagement, will be responsible to develop and execute essential Key Opinion Leader (KOL) customer strategies and tactics that support the launch of RevMed’s lung oncology products with thought leaders within the US.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Education Level
Bachelor's degree